These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 9876028

  • 1. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ.
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [Abstract] [Full Text] [Related]

  • 2. Quantitative and qualitative changes in serum luteinizing hormone after injectable testosterone undecanoate treatment in hypogonadal men.
    Gu YQ, Ge ZY, Zhang GY, Bremner WJ.
    Asian J Androl; 2000 Mar; 2(1):65-71. PubMed ID: 11228940
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial.
    Wang C, Harnett M, Dobs AS, Swerdloff RS.
    J Androl; 2010 Mar; 31(5):457-65. PubMed ID: 20133964
    [Abstract] [Full Text] [Related]

  • 4. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S, Nieschlag E.
    J Androl; 2002 Mar; 23(3):419-25. PubMed ID: 12002444
    [Abstract] [Full Text] [Related]

  • 5. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
    Schubert M, Minnemann T, Hübler D, Rouskova D, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhövel F.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
    Qoubaitary A, Meriggiola C, Ng CM, Lumbreras L, Cerpolini S, Pelusi G, Christensen PD, Hull L, Swerdloff RS, Wang C.
    J Androl; 2006 Nov; 27(6):853-67. PubMed ID: 16837736
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
    Salehian B, Wang C, Alexander G, Davidson T, McDonald V, Berman N, Dudley RE, Ziel F, Swerdloff RS.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
    [Abstract] [Full Text] [Related]

  • 8. Body fat content and testosterone pharmacokinetics determine gonadotropin suppression after intramuscular injections of testosterone preparations in normal men.
    Kornmann B, Nieschlag E, Zitzmann M, Gromoll J, Simoni M, von Eckardstein S.
    J Androl; 2009 Dec; 30(5):602-13. PubMed ID: 19342702
    [Abstract] [Full Text] [Related]

  • 9. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [Abstract] [Full Text] [Related]

  • 10. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
    Moisey R, Swinburne J, Orme S.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
    [Abstract] [Full Text] [Related]

  • 11. More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
    Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhel F, Behre HM, Gooren L, Nieschlag E.
    Asian J Androl; 2007 May; 9(3):291-7. PubMed ID: 17486268
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F, Vogel E, Kreutzer M, Reinhardt W, Lederbogen S, Reinwein D.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [Abstract] [Full Text] [Related]

  • 13. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
    Morgentaler A, Dobs AS, Kaufman JM, Miner MM, Shabsigh R, Swerdloff RS, Wang C.
    J Urol; 2008 Dec; 180(6):2307-13. PubMed ID: 18930255
    [Abstract] [Full Text] [Related]

  • 14. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.
    Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E.
    Eur J Endocrinol; 1999 May; 140(5):414-9. PubMed ID: 10229906
    [Abstract] [Full Text] [Related]

  • 15. Effects of various modes of androgen substitution therapy on erythropoiesis.
    Jockenhövel F, Vogel E, Reinhardt W, Reinwein D.
    Eur J Med Res; 1997 Jul 28; 2(7):293-8. PubMed ID: 9233903
    [Abstract] [Full Text] [Related]

  • 16. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S, Swyer GI, Lawrence DM.
    Acta Eur Fertil; 1977 Dec 28; 8(4):297-9. PubMed ID: 610314
    [Abstract] [Full Text] [Related]

  • 17. Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester.
    Behre HM, Nieschlag E.
    J Clin Endocrinol Metab; 1992 Nov 28; 75(5):1204-10. PubMed ID: 1430080
    [Abstract] [Full Text] [Related]

  • 18. [Effect of androgen on erythropoietin in patients with hypogonadism].
    Cui YG, Tong JS, Pan QQ, Di FS, Jia Y, Feng T, Liu Y, Wang XH, Zhang GY.
    Zhonghua Nan Ke Xue; 2003 Nov 28; 9(4):248-51. PubMed ID: 12931361
    [Abstract] [Full Text] [Related]

  • 19. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
    Jockenhövel F, Blum WF, Vogel E, Englaro P, Müller-Wieland D, Reinwein D, Rascher W, Krone W.
    J Clin Endocrinol Metab; 1997 Aug 28; 82(8):2510-3. PubMed ID: 9253326
    [Abstract] [Full Text] [Related]

  • 20. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
    Lanfranco F, Zitzmann M, Simoni M, Nieschlag E.
    Clin Endocrinol (Oxf); 2004 Apr 28; 60(4):500-7. PubMed ID: 15049966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.